G04.01 Postinfectious acute disseminated encephalitis and encephalomyelitis (postinfectious ADEM)

Name of the Condition

• Postinfectious acute disseminated encephalitis and encephalomyelitis (postinfectious ADEM)

Summary

Postinfectious acute disseminated encephalitis and encephalomyelitis (postinfectious ADEM) is a rare inflammatory disorder of the central nervous system, characterized by widespread demyelination following an infection. It presents with acute neurological symptoms and requires differentiation from other demyelinating or infectious conditions.

Causes

Postinfectious ADEM is an autoimmune response triggered by a preceding infection. The immune system mistakenly attacks myelin, the protective covering of nerve fibers, leading to inflammation and neurological dysfunction. Common triggers include viral infections (e.g., measles, varicella-zoster) or bacterial infections, though the exact mechanism remains under investigation.

Risk Factors

• Recent viral or bacterial infection.
• History of autoimmune disorders.
• Age (more common in children, though it can occur in adults).
• Genetic predisposition to immune-mediated reactions.

Symptoms

• Rapid onset of neurological symptoms, typically within days to weeks of infection.
• Altered mental status, confusion, or behavioral changes.
• Weakness, numbness, or paralysis in limbs.
• Visual disturbances (e.g., blurred vision, optic neuritis).
• Seizures or loss of coordination.
• Fever or headache (less common than in infectious encephalitis).

Diagnosis

Diagnosis involves clinical evaluation, neurological examination, and imaging (e.g., MRI) to identify demyelination. Laboratory tests may rule out infectious causes, and cerebrospinal fluid analysis can support autoimmune etiology. Distinguishing postinfectious ADEM from other demyelinating disorders is critical.

Treatment Options

Treatment focuses on reducing inflammation and managing symptoms. High-dose corticosteroids are commonly used to suppress the immune response. Intravenous immunoglobulin or plasma exchange may be considered for severe cases. Supportive care, including physical therapy, addresses neurological deficits.

Prognosis and Follow-Up

Most patients recover with treatment, though some may experience residual neurological symptoms. Follow-up includes monitoring for relapse or progression. Long-term outcomes vary, with some individuals requiring ongoing rehabilitation or management of chronic symptoms.

Complications

Potential complications include persistent neurological deficits (e.g., weakness, cognitive impairment), seizures, or rare cases of relapsing ADEM. In severe instances, respiratory failure or coma may occur.

Lifestyle & Prevention

Prevention focuses on avoiding known triggers, such as prompt treatment of infections. Vaccinations (e.g., measles, varicella) may reduce infection-related risk. Lifestyle measures include maintaining overall health to support immune function.

When to Seek Professional Help

Seek immediate medical attention for sudden neurological symptoms (e.g., weakness, confusion, seizures) following an infection. Early evaluation is critical to initiate treatment and improve outcomes.

Tips for Medical Coders

Document the postinfectious nature of the condition, including the preceding infection if known. Ensure clinical notes support the diagnosis of demyelination and exclude other causes. Code G04.01 is specific to postinfectious ADEM; verify documentation aligns with this specificity.